uveitis/nausea

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 43 rezilta yo

Cyclosporin A in the treatment of severe Behçet's uveitis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Twelve patients with active Behçet's uveitis with marked deterioration of visual acuity in at least one eye were treated with cyclosporin A (CyA). An initial improvement in the severity of ocular inflammation and systemic features occurred in all cases and persisted until the dose was reduced or the

Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To investigate the therapeutic value of azathioprine as monotherapy or combined with other immunosuppressive drugs for uveitis in patients with juvenile idiopathic arthritis (JIA). METHODS A retrospective multicentre study including 41 children with JIA (28 (68.2%) female) with unilateral

[Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Severe forms of uveitis can often only be managed sufficiently with systemic immunosuppression. All available drugs are known for their relative high rate of side-effects. Mycophenolate mofetil (MMF), an immunosuppressant successfully used in management after organ transplantation and

Low-dose methotrexate treatment in noninfectious uveitis resistant to corticosteroids.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

A total of 14 patients (10 women and 4 men) ranging in age from 18 to 56 years who presented with active chronic noninfectious uveitis were treated with low-dose methotrexate (MTX). All patients had failed to respond to previous systemic corticosteroid therapy. MTX therapy was initiated in 8

[Acute tubulo-interstitial nephritis combined with uveitis (clinical case and review of the literature)].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The authors have presented a review of literature and their own data on acute tubulointerstitial nephritis combined with uveitis in a patient aged 47. In foreign literature this combination is defined as a separate syndrome (TIN-uveitis or TINU). The development of nonspecific symptoms (fatigue,

[Tubulo-interstitial nephritis and uveitis syndrome--TINU syndrome].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Acute tubulo-interstitial nephritis and uveitis (TINU syndrome) in a 53-year-old woman is reported. This rare syndrome was described 27 years ago by Dobrin et al. Since then about 50 cases have been described. The syndrome can appear at any age but most patients are under 20 years; about 75% are

[Tubulointerstitial nephritis-uveitis syndrome (TINU syndrome)].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

For 10 weeks a 25-year-old man had been suffering from tiredness, fatigue, nausea and a 16 kg weight loss. Erythrocyte sedimentation rate (83/133 mm), serum C-reactive protein (5.5 mg/dl) and creatinine (5.05 mg/dl) were all elevated. He also had proteinuria (1120 mg daily), sterile leukocytosis and

The use of low dose methotrexate in children with chronic anterior and intermediate uveitis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE To assess the efficacy of low dose methotrexate (MTX) therapy for children with chronic anterior and intermediate uveitis. METHODS A retrospective case review of 10 children who received MTX for chronic uveitis at a tertiary referral centre was performed. The following data were recorded

Short course of cyclophosphamide therapy may reduce recurrence in patients with tubulointerstitial nephritis and uveitis syndrome.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We report a 43-year-old woman with tubulointerstitial nephritis and uveitis syndrome (TINU syndrome) presented with a 5-day complaint of chills and fever, anorexia, nausea, and vomiting. She had elevated BUN and creatinine and urinalysis revealed decreased concentration, proteinuria, hematuria, and

Tubulointerstitial nephritis and uveitis: report of a rare syndrome.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tubulointerstitial nephritis and uveitis (TINU) is a rare syndrome with unknown pathogenesis. Data have shown a higher prevalence in female gender. We present a man with tubulointerstitial nephritis and uveitis syndrome and antitubular antibody. A 23-year-old man presented with a history of weight

Tubulointerstitial nephritis and uveitis (TINU) syndrome in a 52-year-old female: a case report and review of the literature.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tubulointerstitial nephritis and uveitis (TINU) syndrome is a rare entity first described in 1975, affecting mainly young women and adolescents. We present a case of a 52-year-old female patient (one of the oldest in the literature) who complained of fever, anorexia, nausea, and vomiting. After she

A rare case of acute renal failure due to tubulointerstitial nephritis and uveitis syndrome successfully treated with steroid.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We hereby describe a 49-year-old woman with acute renal failure due to tubulointerstitial nephritis and uveitis (TINU) syndrome. This patient presented with vomiting and nausea and was found to have chronic uveitis, elevated creatinine, and interstitial nephritis. The combination of

FK506 treatment of noninfectious uveitis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE We studied the clinical effects of the immunosuppressive agent FK506 in patients with noninfectious uveitis. METHODS This study was designed as a multicenter open clinical trial in Japan. Sixteen patients with noninfectious uveitis who had visited the Uveitis Survey Clinic of the Yokohama

A Comprehensive Review of mTOR-Inhibiting Pharmacotherapy for the Treatment of Non-Infectious Uveitis.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Non-infectious uveitis is a sight-threatening inflammatory disease that often necessitates prolonged use of high-dose corticosteroids, resulting in significant systemic side effects. There is a need for efficacious steroid-sparing immunomodulatory therapy for these patients, and the mTOR inhibitors

Cyclosporin-A therapy in severe uveitis of Behçet's disease.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Cyclosporine-A (CSA) combined with corticosteroid therapy was administered to 12 patients with severe Behçet's uveitis who were resistant to colchicine or cytotoxic therapy. METHODS Previous colchicine or cytotoxic therapies were tapered off one month before CSA therapy. All patients were

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye